Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
IDDFSDA is an autosomal recessive severe multisystem disorder characterized by poor overall growth, developmental delay, early-onset seizures, intellectual disability, and dysmorphic features. There is phenotypic variability. The most severely affected patients have a neurodevelopmental disorder with microcephaly, absent speech, and inability to walk, and they require feeding tubes. Some patients have congenital heart defects or nonspecific abnormalities on brain imaging. Less severely affected individuals have mild to moderate intellectual disability with normal speech and motor development (summary by {1:Santiago-Sim et al., 2017}).
Features include always present findings: Seizure and Severe intellectual disability; and common findings: Decreased body weight, Short stature, Generalized hypotonia, and Long palpebral fissure and others. 49 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 9 | Inability to walk, Seizure, Spastic tetraplegia |
OTUD6B encodes OTU deubiquitinase 6B (293 aa). Deubiquitinating enzyme that may play a role in the ubiquitin-dependent regulation of protein synthesis, downstream of mTORC1. Highest expression in Cells EBV-transformed lymphocytes (21.9 TPM) and Nerve Tibial (15.1 TPM).
Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies is associated with mutations in the OTUD6B gene on chromosome 8.
OTUD6B is classified as a druggable target (Enzyme category) with score 0.0.
Genetic testing for OTUD6B is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 2 always present features, 18 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies.
2 publications have been identified in PubMed for intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies. Research spans Review / Meta-Analysis (50%) and Case Report / Case Series (50%).
Chen J (2025). [PMID: 41188742](https://pubmed.ncbi.nlm.nih.gov/41188742/). *BMC Pediatr*. [Case Report / Case Series]
Gangaram B (2024). [PMID: 38389298](https://pubmed.ncbi.nlm.nih.gov/38389298/). *Am J Med Genet A*. [Review / Meta-Analysis]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 11:34 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Head and neck |
4 |
Microcephaly, Thin upper lip vermilion, High palate |
Growth and development | 3 | Short stature, Failure to thrive, Intrauterine growth retardation |
Muscles | 3 | Flexion contracture, Generalized hypotonia, Delayed gross motor development |
Arms and legs | 2 | Overlapping toe, Tapered finger |
Digestive system | 2 | Feeding difficulties, Chronic constipation |
Heart and blood vessels | 2 | Ventricular septal defect, Atrial septal defect |
Ears | 1 | Hearing loss (hearing impairment) |
Bones and joints | 1 | Sideways curvature of the spine (scoliosis) |
Age of onset: before birth, infancy.